Lomitapide (JUXTAPID)

Microsomal triglyceride transfer protein (MTP) inhibitor

Lomitapide (JUXTAPID)

Forms and strengths
Form: TabletStrength: 5 mg, 10 mg, 20 mg
Print

Indication

  • Lomitapide is used as an adjunct to a low-fat diet and other lipid-lowering drugs, with or without LDL apheresis, to reduce LDL cholesterol in adults with homozygous familial hypercholesterolemia (HoFH).
  • Because of its safety profile, treatment should be limited to physicians experienced in diagnosing and treating familial hypercholesterolemia.
  • The effect of lomitapide on cardiovascular illness and death has not been established.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.